Targeting bile acids in the treatment of constipation

Expert Review of Gastroenterology and Hepatology

Volumn 5, Issue 6, 2011, Pages 657-659

  Maneerattanaporn, Monthira ^a   Chey, William D ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

A3309; chenodeoxycholic acid; chronic constipation; ileal bile acid transporter; irritable bowel syndrome

Indexed keywords

7 ALPHA HYDROXY 4 CHOLESTEN 3 ONE; A 3309; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLEST 4 EN 3 ONE; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; DIGESTIVE TRACT AGENT; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; BILE ACID METABOLISM; CONSTIPATION; CORRELATIONAL STUDY; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; GASTROINTESTINAL TRACT FUNCTION; HUMAN; IRRITABLE COLON; REVIEW;

BILE ACIDS AND SALTS; CARRIER PROTEINS; CHENODEOXYCHOLIC ACID; COLON; CONSTIPATION; HUMANS; ILEUM; INTESTINAL ABSORPTION; MEMBRANE GLYCOPROTEINS;

EID: 80155212937     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.11.63     Document Type: Review

References (15)

1. Pattni S, Walters JR. Recent advances in the understanding of bile acid malabsorption. Br. Med. Bull. 92, 79-93 (2009).
2. Maneerattanaporn M, Chang L, Chey WD. Emerging pharmacological therapies for the irritable bowel syndrome. Gastroenterol. Clin. North Am. 40(1), 223-243 (2011).
3. Bajor A, Gillberg PG, Abrahamsson H. Bile acids: short and long term effects in the intestine. Scand. J. Gastroenterol. 45(6), 645-664 (2010).
4. Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ, Cook IJ. The proximal colonic motor response to rectal mechanical and chemical stimulation. Am. J. Physiol. Gastrointest. Liver Physiol. 282(3), G443-G449 (2002).
5. Edwards CA, Brown S, Baxter AJ, Bannister JJ, Read NW. Effect of bile acid on anorectal function in man. Gut 30(3), 383-386 (1989).
6. Kirwan WO, Smith AN, Mitchell WD, Falconer JD, Eastwood MA. Bile acids and colonic motility in the rabbit and the human. Gut 16(11), 894-902 (1975).
7. Odunsi ST, Camilleri M, Busciglio I et al. Effects of chenodeoxycholic acid on gastrointestinal and colonic transit and bowel function in healthy volunteers. Gastroenterology 136, A-531 (2009).
8. Dinning PG, Bampton PA, Kennedy ML, Lubowski DZ, King D, Cook IJ. Impaired proximal colonic motor response to rectal mechanical and chemical stimulation in obstructed defecation. Dis. Colon Rectum 48(9), 1777-1784 (2005).
9. Hofmann AF, Loening-Baucke V, Lavine JE et al. Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients. J. Pediatr. Gastroenterol. Nutr. 47(5), 598-606 (2008).
10. Abrahamsson H, Ostlund-Lindqvist AM, Nilsson R, Simren M, Gillberg PG. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand. J. Gastroenterol. 43(12), 1483-1488 (2008).
11. Odunsi-Shiyanbade ST, Camilleri M, Mckinzie S et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin. Gastroenterol. Hepatol. 8(2), 159-165 (2010).
12. Rao AS, Wong BS, Camilleri M et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology 139(5), 1549-1558 (2010).
13. Simren M, Bajor A, Gillberg PG, Rudling M, Abrahamsson H. Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation - a double-blind study. Aliment. Pharmacol. Ther. 34(1), 41-50 (2011).
14. Wong BS, Camilleri M, Mckinzie S, Burton D, Graffner H, Zinsmeister A. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in patients with functional constipation. Gastroenterology 140(5 Suppl. 1), S146-S147 (2011).
15. Chey WD, Camilleri M, Chang L, Rikner L, Graffner H. A randomized placebo-controlled Phase IIb trial of A3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am. J. Gastroenterol. DOI: 10.1038/ ajg.2011.162 (2011) (Epub ahead of print).